FIND YOUR MBC VOICE
COVID-19 INFORMATION AND RESOURCES
Perspectives on COVID-19 from Mace Rothenberg, M.D.
UNDERSTANDING SOCIAL DISTANCING: HOW FAR IS ENOUGH?
HOW TO AVOID PHARMACEUTICAL SCAMS DURING COVID-19
Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer will provide contract manufacturing services at Pfizer’s McPherson, Kansas facility to manufacture and supply remdesivir for Gilead. In March, Pfizer…